• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
AVDL

AVDL

Avadel Pharmaceuticals plc

NASDAQHealthcareDrug Manufacturers - Specialty & GenericIE

USD21.64

+0.00 (+0.00%)

Company Profile

CEO

Gregory J. Divis Jr.

IPO Date

1996-06-07

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

NASDAQ

Country

IE

Market Metrics

Open

$21.64

Prev. Close

$21.64

Day Low

$21.64

Day High

$21.64

52W Low

$6.38

52W High

$23.57

Market Cap

$2.12B

Volume

35.02M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

29.1%

Avg Negative

3.5%

Avg Neutral

67.6%

News Feed

Avadel Pharmaceuticals Announces Publication of Data from Pivotal Phase 3 REST-ON Trial of FT218 in Adults with Narcolepsy in SLEEP

GlobeNewsWire·8/16/2021·↑ positive

Avadel Pharmaceuticals plc (AVDL) CEO Gregory Divis on Q2 2021 Results - Earnings Call Transcript

Seeking Alpha·8/9/2021·↓ negative

Avadel Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2021 Financial Results

GlobeNewsWire·8/9/2021·↑ positive

Avadel Pharmaceuticals, The Jazz-Killer

Seeking Alpha·8/5/2021·↑ positive

Avadel Pharmaceuticals to Present at the Ladenburg Thalmann Annual Healthcare Conference 2021

GlobeNewsWire·7/7/2021·↑ positive

Avadel Pharmaceuticals - A Compelling Buy

Seeking Alpha·5/14/2021·↑ positive

Avadel Pharmaceuticals plc (AVDL) CEO Greg Divis on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/10/2021·↓ negative

Avadel Pharmaceuticals Provides Corporate Update and Reports First Quarter 2021 Financial Results

GlobeNewsWire·5/10/2021·↑ positive

Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2021 Financial Results on May 10th

GlobeNewsWire·4/29/2021·↑ positive

Avadel Presents New Data from its Pivotal REST-ON Phase 3 Trial of FT218, once-nightly sodium oxybate, at the 2021 American Academy of Neurology Annual Meeting

GlobeNewsWire·4/17/2021·↑ positive